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Abstract
Aims To examine the relationship of self-reported diabetes, and of random blood glucose levels among individuals
without known diabetes, with the prevalence of cardiovascular disease in Chinese adults.
Methods We examined cross-sectional data from the China Kadoorie Biobank of 0.5 million people aged 30–79 years
recruited from 10 diverse regions of China in the period 2004–2008. Logistic regression was used to estimate the odds
ratios of prevalent cardiovascular disease associated with self-reported diabetes, and with measured random blood
glucose levels among participants with no history of diabetes, adjusting simultaneously for age, sex, area, education,
smoking, alcohol, blood pressure and physical activity.
Results A total of 3.2% of participants had self-reported diabetes (men 2.9%; women 3.3%) and 2.8% had
screen-detected diabetes (men 2.6%; women 2.8%), i.e. they had no self-reported history of diabetes but a blood glucose
level suggestive of a diagnosis of diabetes. Compared with individuals without a history of diabetes, the odds ratios
associated with self-reported diabetes were 2.18 (95% CI 2.06–2.30) and 1.88 (95% CI 1.75–2.01) for prevalent
ischaemic heart disease and stroke/transient ischaemic attack, respectively. Among participants without self-reported
diabetes there was a positive association between random blood glucose and ischaemic heart disease and stroke/transient
ischaemic attack prevalence (P for trend <0.0001). Below the diabetic threshold (<11.1 mmol/l) each additional 1 mmol/
l of random blood glucose was associated with 4% (95% CI 2–5%) and 5% (95% CI 3–7%) higher odds of prevalent
ischaemic heart disease and stroke/transient ischaemic attack, respectively.
Conclusions In this adult Chinese population, self-reported diabetes was associated with a doubling of the odds of
prevalent cardiovascular disease. Below the threshold for diabetes there was still a modest, positive association between
random blood glucose and prevalent cardiovascular disease.
Diabet. Med. 31, 540–551 (2014)
Introduction
Cardiovascular disease is the leading cause of morbidity and
mortality worldwide [1]. Diabetes is an important risk
factor for cardiovascular disease; patients with diabetes
experience at least a doubling in risk of ischaemic heart
disease and stroke compared with those without diabetes
[2]. There is also evidence to suggest that higher blood
glucose levels below the threshold for diabetes may increase
the risk of cardiovascular disease [2]. In China, the
incidence of diabetes has risen rapidly over recent decades
[3], but there is limited evidence for the association of
diabetes with cardiovascular disease [4,5], which, in con-
trast to most Western populations, is characterized in the
Chinese population by higher rates of stroke and lower rates
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of ischaemic heart disease [6]. Moreover, uncertainty
remains about the association of blood glucose with the
risk of cardiovascular disease among the Chinese population
without diabetes [7].
To help address these issues, we report cross-sectional data
from the China Kadoorie Biobank of 0.5 million people [8].
The objectives were to examine: 1) the relationship between
self-reported, doctor-diagnosed diabetes and the prevalence
of cardiovascular disease; 2) the relevance of age, sex, area,
education, smoking status, alcohol consumption, blood
pressure, physical activity and adiposity to observed associ-
ations; and 3) the association between random blood glucose
levels and the prevalence of cardiovascular disease among
people without prior diabetes.
Patients and methods
Study population
The study design and characteristics of the China Kadoorie
Biobank population have been described previously [8,9].
A total of 512 891 men and women aged 30–79 years
were recruited between 2004 and 2008 from five urban
and five rural areas in China (Fig. 1). The areas were
chosen according to local disease patterns, exposure to
certain risk factors, population stability, levels of economic
development, death and disease registry quality and
practical considerations, including local capacity and com-
mitment. In each area, permanent residents of 100–150
administrative units (rural villages or urban residential
committees) were identified through official residential
records, then invited to participate by letter after extensive
publicity campaigns. The population response rate was
~30%.
FIGURE 1 Locations of the China Kadoorie Biobank recruitment centres. Black circles represent urban areas, white circles represent rural areas.
What’s new?
• Little is known about the role of diabetes as a risk
factor for cardiovascular disease in the Chinese popu-
lation. Below the threshold for diabetes, substantial
uncertainty exists about the association of blood
glucose levels with cardiovascular disease in Chinese
populations and more generally.
• Data from the China Kadoorie Biobank of 0.5 million
middle-aged Chinese adults demonstrated a doubling of
the odds of prevalent ischaemic heart disease and
stroke/transient ischaemic attack among people with
self-reported diabetes. Among people without prior
diabetes, blood glucose levels were positively associated
with prevalent cardiovascular disease.
• A comprehensive understanding of the role of both
blood glucose levels and diabetes in cardiovascular
disease risk is fundamental to effective disease preven-
tion and control.
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Data collection
Data were obtained from participants through inter-
viewer-administered electronic questionnaires, collating
information on demographic and socio-economic character-
istics, lifestyle, personal and family medical history (includ-
ing a history of doctor-diagnosed diabetes, ischaemic heart
disease —including myocardial infarction and angina — and
stroke/transient ischaemic attack) and current medication
amongst those reporting ischaemic heart disease, stroke/
transient ischaemic attack, hypertension or diabetes. A range
of physical measurements were undertaken by trained
technicians, including height, weight, hip and waist circum-
ference, bio-impedance and blood pressure, using calibrated
instruments with standard protocols.
A 10-ml non-fasting (except in one study area where
participants were asked to fast) blood sample was collected
from participants into an ethylenediamine tetra-acetic acid
vacutainer (BD HemogardTM, BD, Franklin Lakes, NJ,
USA), with the time since the participant last ate recorded.
On-site testing of plasma glucose level was undertaken using
the SureStep Plus meter (LifeScan, Milpitas, CA, USA).
Participants with glucose levels ≥7.8 mmol/l and
<11.1 mmol/l were invited to return for a fasting blood
glucose test the next day. Random blood glucose data were
unavailable for 8160 participants without self-reported
diabetes (because of a delay in making the on-site test
available in certain regions). Screen-detected diabetes was
defined as no self-reported diabetes with a blood glucose
level ≥7.0 mmol/l and a fasting time >8 h, a blood glucose
level ≥11.1 mmol/l and a fasting time <8 h, or a fasting
blood glucose level ≥7.0 mmol/l.
Ethical approval for the study was obtained from Oxford
University, the China National Centre for Disease Control
and Prevention and the 10 study areas’ local Centres for
Disease Control and Prevention. All participants provided
informed, written consent.
Statistical analyses
Sex-specific, age- and study area-adjusted random blood
glucose levels in the population without self-reported diabetes
were compared across categories of other variables using
general linear models. Prevalence of self-reported and screen-
detected diabetes were compared across levels of other
variables, standardized to 5-year age groups and study area.
The associations of self-reported and screen-detected
diabetes, and of random blood glucose level amongst people
without self-reported diabetes, with the prevalence of
ischaemic heart disease and stroke/transient ischaemic attack
were examined using multivariate logistic regression. Ran-
dom blood glucose was categorized into six groups (thresh-
olds: 4.8, 5.8, 6.8, 7.8 and 11.1 mmol/l), selected to include
the oral glucose tolerance test 2-h post glucose-load thresh-
olds for impaired glucose tolerance and diabetes [10]. Odds
ratios for cardiovascular disease were calculated, adjusting
simultaneously for age, study area, education (no formal
schooling, primary school, middle school, high school,
college/university), smoking (never, occasional, ex-regular,
current regular), and alcohol (never regular, occasional
intake, ex-regular, reduced intake, weekly intake). In sepa-
rate models, additional adjustments were made for systolic
blood pressure (thresholds: 100, 110, 120, 130, 140, 150,
160 and 170 mmHg) and physical activity (thresholds: 10,
20, 30, 40 metabolic equivalent of task h/day), and for
waist–hip ratio (thresholds: 0.75, 0.80, 0.85, 0.90 and 0.95).
For random blood glucose analyses, the floating absolute
risk method was used to provide estimates of variance across
all exposure categories [11]. Chi-squared tests for trend in log
odds ratios were conducted and the estimated odds ratios of
prevalent ischaemic heart disease and stroke/transient ischae-
mic attack were examined for departure from linearity by
testing the type 3 chi-square for categorical random blood
glucose, in a model that contained random blood glucose as a
categorical and a continuous variable. The odds ratios for
each additional 1 mmol/l of random blood glucose were
estimated in participants with a random blood glucose level
<11.1 mmol/l. In participants with neither self-reported nor
screen-detected diabetes, random blood glucose analyses were
repeated, stratified by fasting time (<8 vs ≥8 h). The 8-h
threshold was based on fasting duration guidance [12] and
evidence of a threshold in the relationship between random
blood glucose and fasting time at 8 h in the China Kadoorie
Biobank. Adjusted odds ratios associated with self-reported
diabetes were compared across strata of sex, age, rural/urban,
education, smoking status, alcohol consumption, systolic
blood pressure, physical activity, adiposity and treatment
status (which was additionally adjusted for duration of
diabetes diagnosis); chi-squared tests for trend and heteroge-
neity were applied to the estimates for each variable [13].
Statistical analyses were conducted using SAS version 9.3
(SAS Institute Inc., Cary, North Carolina, USA).
Results
Overall, 2.9% of men and 3.3% of women reported a history
of doctor-diagnosed diabetes and a further 2.6% of men and
2.8% of women had screen-detected diabetes. Total diabetes
prevalence (combined self-reported and screen-detected
diabetes) increased with age, and was higher in urban than
in rural areas (Table 1). Ex-regular smokers and drinkers
had the highest self-reported diabetes prevalence compared
with other smoking or alcohol categories (Table 1). Screen-
detected diabetes prevalence was highest amongst ex-regular
smokers, but not ex-regular drinkers. There was a strong
inverse association between physical activity and diabetes
prevalence. Participants with a family history of diabetes
were four times as likely to have doctor-diagnosed diabetes
and approximately twice as likely to have screen-detected
diabetes as those without such a family history (Table 1).
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Diabetes prevalence was strongly positively associated with
systolic blood pressure and adiposity (Table 2).
Mean (SE) age- and area-adjusted random blood glucose
was 5.8 (<0.1) mmol/l in men and 6.0 (<0.1) mmol/l in
women without self-reported diabetes. Random blood glu-
cose varied little by socio-economic or lifestyle factors, but
increased with increasing age (Table 1), systolic blood
pressure and adiposity (Table 2).
A total of 2.7% of men and 3.2% of women reported a
history of doctor-diagnosed ischaemic heart disease, higher
than for stroke/transient ischaemic attack (men 2.3%; women
1.3%). The prevalence of ischaemic heart disease and of
stroke/transient ischaemic attack increased with increasing
age, and were higher in urban than in rural areas (ischaemic
heart disease: 4.6 vs 1.7%; stroke/transient ischaemic attack:
2.3 vs 1.3%). After adjusting for age, area, education,
Table 1 Demographic and lifestyle characteristics of China Kadoorie Biobank participants by sex
Characteristic

























30–39 29594 0.7 1.1 5.3 48210 0.3 0.8 5.5
40–49 59230 1.7 2.1 5.6 93519 1.2 1.9 5.8
50–59 63715 3.3 3.0 5.9 93841 3.9 3.5 6.1
60–69 41331 4.9 3.5 6.1 50440 7.2 4.7 6.4
70–79 16352 5.3 4.0 6.2 16659 7.1 4.8 6.4
Rural/urban
Rural 118883 1.6 1.8 5.6 167822 2.4 2.5 5.9
Urban 91339 4.6 3.7 6.0 134847 4.3 3.2 6.0
Highest level of education
No formal schooling 18660 2.8 4.1 5.8 76561 3.4 3.8 6.0
Primary school 70110 2.7 2.9 5.8 95106 3.6 3.2 6.0
Middle school 68172 3.3 2.8 5.8 76741 4.0 2.8 5.9
High school 36727 3.5 2.9 5.8 40800 4.0 2.4 5.8
College or university 16553 4.1 2.7 5.7 13461 3.8 2.0 5.8
Annual household income (Yuan/year)
<2500 6154 2.4 3.7 5.8 9392 2.9 3.9 5.9
2500–4999 13300 2.8 3.1 5.8 21357 3.1 3.0 6.0
5000–9999 35283 2.8 2.3 5.8 59346 3.5 2.7 6.0
10 000–19 999 59558 2.9 2.6 5.8 89455 3.3 3.0 6.0
20 000–34 999 53400 3.1 2.7 5.8 73321 3.4 2.8 6.0
≥35 000 42527 3.8 3.4 5.8 49798 4.1 2.7 6.0
Smoking
Never 30281 3.2 2.6 5.8 287333 3.3 2.8 6.0
Occasional 23628 3.0 2.5 5.8 5531 3.9 3.2 6.0
Ex-regular 27918 4.1 2.9 5.9 2645 4.9 5.8 6.0
Current regular 128395 2.4 2.6 5.8 7160 4.0 4.3 5.9
Alcohol
Never regular 42764 3.8 2.8 5.8 192435 4.0 3.0 6.0
Occasional 79260 2.7 2.3 5.8 101328 2.4 2.6 5.9
Ex-regular 7923 7.0 2.6 5.9 1333 8.0 3.3 5.9
Reduced intake 10371 5.5 2.6 5.8 1325 3.4 2.8 6.0
Weekly 69904 1.9 2.8 5.8 6248 1.2 2.2 5.9
Physical activity (metabolic equivalent of task h/day)
<10 23487 4.3 3.7 5.9 15293 5.4 3.7 6.0
10-19.9 61366 3.7 2.8 5.8 118436 3.9 3.0 6.0
20-29.9 46417 2.8 2.5 5.8 81247 2.9 2.7 5.9
30-39.9 36948 1.8 2.5 5.8 45148 2.3 2.6 5.9
≥40 42004 1.5 2.4 5.8 42545 1.5 2.1 5.9
Family history of diabetes¶,**
No 182986 2.4 2.5 5.8 268510 2.7 2.7 5.9
Yes 14225 10.7 4.7 6.1 22347 11.5 4.7 6.2
Fasting time (h)
<8 168500 2.7 2.4 5.9 233913 2.9 2.4 6.1
≥8 41722 5.1 3.9 5.3 68756 6.2 4.1 5.5
*Standardized to the age and study area structure of the study population; †adjusted for age and study area; ‡all SE values ≤0.1; §adjusted for/
standardized to study area only; ¶first-degree relatives; **data missing for 24 823 participants.
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smoking, alcohol, systolic blood pressure and physical activ-
ity, individuals with self-reported diabetes were more than
twice as likely to have ischaemic heart disease (men: odds ratio
2.15, 95% CI 1.96–2.36; women: odds ratio 2.19, 95% CI
2.05–2.34) than those without (Table 3). Similar findings
were observed for stroke/transient ischaemic attack, with a
somewhat greater odds ratio in women (odds ratio 2.08, 95%
CI 1.89–2.29) than in men [odds ratio 1.64, 95% CI 1.48–
1.82 (P for interaction=0.0006)]. Adjusted odds ratios for
prevalent ischaemic heart disease (IHD) with self-reported
diabetes were similar across the strata of other risk factors
with the exception of age and BMI, with a higher odds in
participants aged 30–59 years (P = 0.001 for trend), and
increasing odds with increasing BMI [P < 0.001 for trend
(Fig. 2)]. The odds ratios for prevalent stroke/transient
ischaemic attack increased with increasing physical activity
levels (P = 0.02 for trend) but varied little by other risk factors
(Fig. 3). Further adjustment for waist–hip ratio moderately
attenuated both associations.
Of the 13 678 (84.6%) participants with self-reported
diabetes with data available on hypoglycaemic medication
use, 76.9% reported taking such medication (84.7% oral
hypoglycaemics; 18.9% insulin). The odds ratio for ischae-
mic heart disease, after adjustment for other cardiovascular
disease risk factors, was significantly higher in participants
reporting hypoglycaemic medication use than in those not
using such medication (odds ratio 2.25 vs 1.69; P for
heterogeneity <0.001; Fig. S1). This difference was minimally
Table 2 Characteristics of China Kadoorie Biobank participants from physical examination by sex
Characteristic


























<100 mmHg 3940 2.0 1.1 5.5 13595 1.3 1.2 5.7
100–119 mmHg 50915 2.0 1.5 5.6 94810 2.0 1.6 5.8
120–139 mmHg 90876 2.8 2.4 5.8 110743 3.0 2.7 6.0
140–159 mmHg 43526 3.5 3.7 6.0 53187 4.6 4.1 6.2
≥160 mmHg 20965 4.1 4.8 6.1 30334 5.5 5.3 6.2
BMI§
<18.5 kg/m2 9426 1.8 1.7 5.7 12947 1.7 1.7 5.7
18.5 to <22.5 kg/m2 77017 2.0 1.7 5.6 99120 2.7 1.7 5.8
22.5 to <25 kg/m2 58581 3.1 2.5 5.8 86868 3.4 2.6 5.9
25 to <30 kg/m2 58975 3.9 3.8 6.0 88990 3.9 3.9 6.1
≥30 kg/m2 6222 5.5 6.4 6.4 14743 4.9 5.9 6.5
Waist circumference
<70 cm 21361 1.2 1.3 5.6 50518 1.4 1.2 5.7
70–79.9 cm 70042 1.8 1.5 5.6 117308 2.6 1.9 5.8
80–89.9 cm 72494 3.2 2.6 5.8 94766 3.8 3.4 6.1
90–99.9 cm 38021 4.3 4.3 6.1 33317 5.0 5.3 6.4
≥100 cm 8304 5.9 7.0 6.5 6760 7.0 7.8 6.8
Hip circumference
<84 cm 33453 1.9 2.2 5.7 40403 2.7 2.2 5.8
84–87.9 cm 41832 2.3 1.9 5.7 58436 3.5 2.5 5.9
88–91.9 cm 48447 2.9 2.4 5.8 73849 3.4 2.6 5.9
92–95.9 cm 40464 3.4 2.9 5.8 61553 3.4 3.0 6.0
≥96 cm 46026 3.8 3.9 6.0 68428 3.6 3.8 6.1
Waist–hip ratio
<0.75 987 1.1 1.8 5.5 9793 1.0 1.0 5.5
0.75–0.80 8073 1.1 1.2 5.5 36890 1.2 1.1 5.6
0.80–0.85 29810 1.2 1.2 5.5 72148 1.9 1.6 5.8
0.85–0.90 55847 2.1 1.7 5.6 83560 3.0 2.5 5.9
0.90–0.95 60599 3.0 2.5 5.8 60535 4.3 3.9 6.2
≥0.95 54906 4.8 4.6 6.2 39743 6.5 6.4 6.6
Percentage body fat¶
<15 27510 2.1 1.4 5.7 1125 2.0 2.1 5.9
15–24.9 117804 2.8 2.0 5.7 45652 2.3 1.4 5.8
25–34.9 59762 3.7 4.1 6.0 157011 3.3 2.3 5.9
≥35 5022 4.1 6.9 6.3 98764 3.8 4.3 6.1
*Standardized to the age and study area structure of the study population; †adjusted for age and study area; ‡all SE values ≤0.1; §data missing
for two participants; ¶ data missing for 241 participants.
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attenuated after adjustment for duration of diabetes diagno-
sis. The risk of prevalent stroke/transient ischaemic attack
was non-significantly elevated in those who reported use of
hypoglycaemic medications (P for heterogeneity 0.1; Fig. S1).
After adjustment for age, area, education, smoking,
alcohol, systolic blood pressure and physical activity, there
was no significant difference in the odds of prevalent
ischaemic heart disease (men: odds ratio 0.92, 95% CI




diabetes Age-adjusted Model A Model B Model C
Events/ Participants Events/ Participants OR 95%CI OR 95%CI OR 95%CI OR 95%CI
Ischaemic heart disease
Men 683/ 6124 5031/ 204098 3.37 (3.09–3.68) 2.25 (2.06–2.47) 2.15 (1.96–2.36) 2.00 (1.82–2.19)
Women 1370/ 10038 8388/ 292631 3.03 (2.85–3.23) 2.31 (2.16–2.47) 2.19 (2.05–2.34) 2.04 (1.90–2.18)
Stroke/transient ischaemic attack
Men 505/ 6124 4407/ 204098 2.76 (2.51–3.05) 1.85 (1.67–2.06) 1.64 (1.48–1.82) 1.55 (1.39–1.72)
Women 602/ 10038 3370/ 292631 3.06 (2.80–3.36) 2.48 (2.25–2.72) 2.08 (1.89–2.29) 1.93 (1.75–2.12)
Model A: adjusted for age, study area, education, smoking, alcohol; Model B: additionally adjusted for systolic blood pressure and physical
activity; Model C: additionally adjusted for waist–hip ratio. OR, odds ratio.
0.5 1.0 2.0 3.0 4.0
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2.59 (2.36 − 2.85)
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2.37 (2.11 − 2.66)
2.15 (2.02 − 2.28)
2.13 (1.86 − 2.45)
2.19 (1.99 − 2.42)
2.20 (1.98 − 2.45)
2.15 (1.88 − 2.46)
1.86 (1.58 − 2.20)
2.17 (2.03 − 2.32)
2.10 (1.62 − 2.73)
2.01 (1.74 − 2.32)
2.34 (2.03 − 2.69)
2.07 (1.93 − 2.23)
2.43 (2.19 − 2.69)
1.73 (1.34 − 2.23)
1.94 (1.51 − 2.49)
2.68 (2.21 − 3.26)
2.21 (2.05 − 2.37)
2.12 (1.94 − 2.32)
2.28 (1.87 − 2.76)
1.90 (1.74 − 2.07)
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2.26 (2.02 − 2.52)
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events OR (95% CI)
FIGURE 2 Odds ratios (ORs) for prevalent ischaemic heart disease by self-reported diabetes status. Adjusted for age, sex, study area, education,
smoking, alcohol, systolic blood pressure, physical activity. Closed squares represent the OR with area inversely proportional to the variance.
Horizontal lines represent the corresponding 95% CIs. The dotted line indicates the overall OR. The open diamond represents the overall OR and its
95% CI. BMI, body mass index; MET, metabolic equivalent of task; SBP, systolic blood pressure.
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0.80–1.07; women: odds ratio 0.91, 95% CI 0.82–1.01) or
stroke/transient ischaemic attack (men: odds ratio 0.95, 95%
CI 0.81–1.10; women: odds ratio 1.15, 95% CI 1.00–1.32)
between individuals with screen-detected diabetes and those
without any diabetes.
Among participants without self-reported diabetes, there
was a positive association between random blood glucose
levels and ischaemic heart disease prevalence, with adjusted
odds ratios of 1.00, 0.99, 1.05, 1.14, 1.18 and 1.13 at
random blood glucose levels of <4.8 (reference), 4.8–5.7,
5.8–6.7, 6.8–7.7, 7.8–11.0 and ≥11.1 mmol/l, respectively
(P for trend <0.0001). After further adjustment for systolic
blood pressure and physical activity, the odds ratios were
attenuated, but a significant trend remained (P for trend
<0.0001; Fig. 4). Below 11.1 mmol/l there was no significant
deviation from log-linearity of the association, with each
additional 1 mmol/l of random blood glucose associated
with 4% (95% CI 2–5%) higher odds of prevalent ischaemic
heart disease. The prevalence of stroke/transient ischaemic
attack increased with higher random blood glucose levels,
with adjusted odds ratios of 1.00, 1.06, 1.14, 1.23, 1.35 and
1.64 at random blood glucose levels of <4.8 (reference),
4.8–5.7, 5.8–6.7, 6.8–7.7, 7.8–11.0 and ≥11.1 mmol/l,
respectively (P for trend <0.0001). Additional adjustment
for systolic blood pressure and physical activity attenuated
the associations, but the trend remained significant and did
not deviate significantly from log-linearity (P for trend
<0.0001; Fig. 5). Below 11.1 mmol/l, each additional
1 mmol/l of random blood glucose was associated with 5%
(95% CI 3–7%) greater odds of prevalent stroke/transient
ischaemic attack. Additional adjustment for waist–hip ratio
attenuated the associations of random blood glucose with
ischaemic heart disease (odds ratios of 0.96, 1.00, 1.05, 1.06
and 0.93 at random blood glucose levels of 4.8–5.7, 5.8–6.7,
6.8–7.7, 7.8–11.0 and ≥11.1 mmol/l compared with
<4.8 mmol/l; P for trend 0.046) and stroke/transient ischae-
0.5 1.0 2.0 3.0 4.0
1.64 (1.47 − 1.82)
2.08 (1.89 − 2.29)
2.00 (1.76 − 2.27)
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1.78 (1.48 − 2.14)
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2.15 (1.60 − 2.90)
1.51 (1.28 − 1.79)
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1.94 (1.71 − 2.20)
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2.07 (1.63 − 2.63)
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events OR (95% CI)
FIGURE 3 Odds ratios (ORs) for prevalent stroke/transient ischaemic attack by self-reported diabetes status. Adjusted for age, sex, study area,
education, smoking, alcohol, systolic blood pressure, physical activity. Closed squares represent the OR with area inversely proportional to the
variance. Horizontal lines represent the corresponding 95% CIs. The dotted line indicates the overall OR. The open diamond represents the overall
OR and its 95% CI. BMI, body mass index; MET, metabolic equivalent of task; SBP, systolic blood pressure.
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mic attack (odds ratios of 1.04, 1.07, 1.12, 1.17 and 1.21; P
for trend <0.0001). There was no significant difference in the
association of fasting and non-fasting blood glucose with the
prevalence of ischaemic heart disease or stroke/transient
ischaemic attack (Fig. S2).
Discussion
The present study is the largest cross-sectional study on the
associations of diabetes, and of blood glucose levels among
adults without diabetes, with cardiovascular disease in a
Chinese population. The study showed an independent
doubling of the odds of prevalent ischaemic heart disease
and stroke/transient ischaemic attack associated with self-
reported diabetes. Amongst individuals without diabetes
diagnoses there was an apparent positive association of
random blood glucose levels with both these conditions.
A few Chinese studies have previously reported the
positive association of diabetes with prevalent IHD. The
China National Diabetes and Metabolic Disorders Study, a
nationally representative survey of >45 000 adults aged
≥20 years, found that diabetes (based on self-report and oral
glucose tolerance test) was associated with an odds ratio of
2.44 for ischaemic heart disease [4]. In another study of
almost 60 000 adults aged >40 years in rural Beijing,
self-reported diabetes was associated with an odds ratio of
2.51 for ischaemic heart disease [5]. Our point estimates are
lower, but not inconsistent with these studies; the differences
may reflect different disease definitions [4,5] or variable
adjustment for confounders [5]. Our findings are more
consistent with prospective studies, which have tended to
adjust for confounders more comprehensively. In a large,
individual participant data meta-analysis of almost 700 000
people from predominantly Western populations, diabetes
(defined variably by self-report, medication use or fasting
blood glucose levels) was associated with a doubling of risk
for ischaemic heart disease in a fully adjusted model [14]. In
the Asia Pacific Cohort Studies Collaboration individual
participant data meta-analysis involving 161 214 partici-
pants, self-reported diabetes was associated with a 73%
excess risk of ischaemic heart disease after adjustment for
sex, study and age, which persisted after further adjustment
for systolic blood pressure, cholesterol, obesity and smoking
[15].
Glycaemic thresholds for diabetes are based on elevated
microvascular disease risk [10] and may be less relevant to
macrovascular disease [2]. One cross-sectional US study of
2500 individuals without known diabetes but with hyper-
tension or hyperlipidaemia, found a significantly elevated
independent risk of self-reported ischaemic heart disease
(n = 1274) at all fasting blood glucose levels > 4.8 mmol/l
compared with < 4.4 mmol/l [16]. To our knowledge, no
studies in mainland China have published data on the
association of blood glucose with ischaemic heart disease or
stroke risk amongst individuals without diabetes. One






















FIGURE 4 Odds ratios (ORs) for prevalent ischaemic heart disease by
random blood glucose levels in participants without self-reported
diabetes. Adjusted for age, sex, study area, education, smoking,
alcohol, systolic blood pressure and physical activity. ORs are plotted
against mean random blood glucose level in each group (<4.8/4.8–5.7/
5.8–6.7/6.8–7.7/7.8–11.0/≥11.1 mmol/l). Squares represent the OR
with area inversely proportional to the variance. Vertical lines
represent the corresponding 95% CIs. Numbers above the CIs are the
ORs and numbers below the CIs are represent participants with
self-reported ischaemic heart disease.

























FIGURE 5 Odds ratios (ORs) for prevalent stroke/transient ischaemic
attack by random blood glucose levels in participants without
self-reported diabetes. Adjusted for age, sex, study area, education,
smoking, alcohol, systolic blood pressure and physical activity. ORs
are plotted against mean random blood glucose level in each group
(<4.8/4.8–5.7/5.8–6.7/6.8–7.7/7.8–11.0/≥11.1 mmol/l). Squares
represent the OR with area inversely proportional to the variance.
Vertical lines represent the corresponding 95% CIs. Numbers above
the CIs are the ORs and numbers below the CIs represent participants
with self-reported stroke/transient ischaemic attack.
ª 2013 The Authors.
Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK. 547
Research article DIABETICMedicine
prospective study involving 16 500 individuals without
diabetes in Taiwan showed no significant association of
composite cardiovascular disease deaths with post-challenge
(relative risk 1.61, 95% CI 0.86–2.99) or fasting (relative
risk 0.84, 95% CI 0.47–1.51) blood glucose, comparing the
highest and lowest quintiles [7]. Several prospective studies
have found an increased risk of ischaemic heart disease only
at or above glycaemic thresholds for diabetes, impaired
glucose tolerance or impaired fasting glucose [14,17,18]. An
individual participant data meta-analysis, including > 250
000 participants without known diabetes and ~13 000
ischaemic heart disease events, found a significantly elevated
risk only at fasting blood glucose levels > 6.1 mmol/l [14].
Other studies, however, have reported a significant positive
association within the ‘normoglycaemic’ range [19,20]; the
Asia Pacific Cohort Studies Collaboration found a log-linear
association with ischaemic heart disease extending down to a
fasting blood glucose level of 4.9 mmol/l [19]. These
apparent inconsistencies may reflect differences in popula-
tions studied, sample size, glycaemic measures, adjustment
for confounders or intra-individual variation in blood
glucose levels and reverse causality. Few studies have
examined the relationship with random blood glucose but,
in contrast to the findings presented, a published data
meta-analysis including almost 10 000 participants and
~300 ischaemic heart disease events showed no significant
association of random blood glucose with fatal ischaemic
heart disease (hazard ratio 1.02), although the level of
adjustment is unclear [20]. Our main results were based on
random blood glucose, but there was no material difference
in associations after stratifying by fasting time, although the
statistical power was limited by small event numbers in some
categories. Our main analyses did not adjust for adiposity as
it is causally related to diabetes and increased random blood
glucose, as confirmed by significant attenuation of associa-
tions between random blood glucose and prevalent cardio-
vascular disease after adjustment for adiposity.
Evidence on the association of diabetes with stroke in
Chinese populations is limited. In the cross-sectional rural
Beijing study, self-reported diabetes was associated with a
twofold greater prevalence of stroke [5]. Several large
prospective studies of non-Chinese populations [21–23],
including meta-analyses [15], have shown an approximately
one-and-a-half to threefold greater risk of total stroke asso-
ciated with diabetes [15,21,24], similar to our study findings.
We found significantly higher odds of prevalent stroke/
transient ischaemic attack, but not ischaemic heart disease,
amongst women than men. A more adverse diabetes-associ-
ated risk profile for cardiovascular disease in women and
treatment differences favouring men have been suggested as
possible explanations for the greater risk in women [24,25].
Associations between blood glucose levels and stroke have
been examined primarily in non-Chinese populations
[18,19,26]. Two large studies showed positive associations
of fasting blood glucose with stroke risk within the ‘normo-
glycaemic’ range [18,19]. A study of >15 000 adults in
Scotland estimated hazard ratios of 1.07 and 1.12 for total
stroke in men and women, respectively, per 1 SD higher
random blood glucose [27]. The stronger relationship of
random blood glucose with stroke/transient ischaemic attack
than with ischaemic heart disease in the China Kadoorie
Biobankwas also observed for fasting blood glucose in a study
of Korean men [18], but this contrasts with studies in many
Western populations demonstrating no difference [27] or
possibly a stronger association with ischaemic heart disease
than with stroke [28]. The role of small vessel pathology in
cerebrovascular disease, thought to be particularly prominent
in Chinese populations [29], could explain the stronger
association with stroke/transient ischaemic attack.
Previous studies have shown nonsignificantly lower risks of
ischaemic heart disease or stroke in screen-detected diabetes
(or amongst individuals with a comparable glycaemic status)
than in self-reported diabetes [14,17,26]. The markedly
lower odds of cardiovascular disease associated with screen-
detected than with self-reported diabetes in the present study
may reflect shorter disease duration or less severe glycaemic
aberrations in screen-detected diabetes, selective diagnosis of
diabetes amongst individuals with cardiovascular disease or a
greater proportion of false-positive diabetes diagnoses in the
screen-detected group.
The size and diversity of the China Kadoorie Biobank
data enable reliable estimates of the relationships of diabetes
and blood glucose levels with prevalent cardiovascular
disease. Although not designed to be nationally representa-
tive, the estimated diabetes prevalence of 5.9% is reason-
ably consistent with estimates from nationally representative
surveys in China [30,31]. In the China National Diabetes
and Metabolic Disorder Study, self-reported ischaemic heart
disease and stroke prevalences were <1% [4]. In contrast,
the rural Beijing study reported ischaemic heart disease and
stroke prevalences of 5.6% and 3.7%, respectively [5],
higher than estimates in the present study. Differences
between studies probably reflect differences in disease
definitions, sampling schemes and populations or temporal
trends [3,5].
Self-reporting of diabetes is prone to error but in a 2008
resurvey of ~20 000 randomly selected China Kadoorie
Biobank participants, ~90% of participants who reported
diabetes at baseline again reported a history of diabetes.
Arguably, more robust approaches to glycaemic status
assessment exist but are less feasible in large population-based
studies. The cross-sectional design is susceptible to bias from
reverse causality. Since diabetes has been associated with a
higher fatal than non-fatal risk of cardiovascular disease [14]
and higher cardiovascular disease mortality rates [32], the use
of non-fatal outcomes — and potentially less severe forms —
could underestimate associations. Furthermore, a known
diagnosis of diabetes could bias self-reporting of cardiovas-
cular disease. Our inability to adjust for the effects of lipids
may have produced residual confounding.
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Our analyses provide clear evidence of an independently
elevated prevalence of ischaemic heart disease and stroke/
transient ischaemic attack associated with self-reported dia-
betes. They also provide supportive evidence of associations
of random blood glucose levels below the diabetic threshold
with prevalent stroke/transient ischaemic attack and possibly
with ischaemic heart disease, although their independence is
unclear. Multiple pathophysiological explanations for asso-
ciations of diabetes and blood glucose levels with cardiovas-
cular disease exist [2], and a sound understanding of the role
of both exposures in determining ischaemic heart disease and
stroke risk is fundamental to effective prevention and control
of cardiovascular disease in Chinese and other populations.
Continuing follow-up for incident ischaemic heart disease
and stroke among the China Kadoorie Biobank participants
will provide large-scale prospective evidence about these
relationships.
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Figure S1 Odds ratios (OR) for prevalent CVD by
hypoglycaemic medication treatment status in selfreported
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Figure S2 Odds ratios (OR) for (a) prevalent IHD and (b)
prevalent stroke/TIA by random blood glucose levels in
participants without diabetes (self-reported or screen-de-
tected) by fasting time.
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